TY - JOUR
T1 - Skin Graft Take and Healing Following 193-nm Excimer, Continuous-Wave Carbon Dioxide (CO2), Pulsed CO2, or Pulsed Holmium:YAG Laser Ablation of the Graft Bed
AU - Green, Howard A.
AU - Burd, Elizabeth E.
AU - Nishioka, Norman S.
AU - Compton, Carolyn C.
N1 - Funding Information:
AcceptedforpublicationDecember 17, 1992. Thisworkwas supported by grant ROI GM35242 from theNationalInstitutes of Health, Bethesda, Md; grant 15880
PY - 1993/8
Y1 - 1993/8
N2 - Background: Ablative lasers have been used for cutaneous surgery for greater than two decades since they can remove skin and skin lesions bloodlessly and efficiently. Because full-thickness skin wounds created after thermal laser ablation may require skin grafting in order to heal, we have examined the effect of the residual laser-induced thermal damage in the wound bed on subsequent skin graft take and healing. In a pig model, four different pulsed and continuous-wave lasers with varying wavelengths and radiant energy exposures were used to create uniform fascial graft bed thermal damage of approximately 25,160, 470, and 1100 μm. Meshed split-thickness skin graft take and healing on the thermally damaged fascial graft beds were examined on a gross and microscopic level on days 3 and 7, and then weekly up to 42 days. Results: Laser-induced thermal damage on the graft bed measuring greater than 160±60 μm in depth significantly decreased skin graft take. Other deleterious effects included delayed graft revascularization, increased inflammatory cell infiltrate at the graft-wound bed interface, and accelerated formation of hypertrophied fibrous tissue within the graft bed and underlying muscle. Conclusions: Ablative lasers developed for cutaneous surgery should create less than 160 ±60 μm of residual thermal damage to permit optimal skin graft take and healing. Pulsed carbon dioxide and 193-nm excimer lasers may be valuable instruments for the removal of full-thickness skin, skin lesions, and necrotic tissue, since they create wound beds with minimal thermal damage permitting graft take comparable to that achieved with standard surgical techniques.
AB - Background: Ablative lasers have been used for cutaneous surgery for greater than two decades since they can remove skin and skin lesions bloodlessly and efficiently. Because full-thickness skin wounds created after thermal laser ablation may require skin grafting in order to heal, we have examined the effect of the residual laser-induced thermal damage in the wound bed on subsequent skin graft take and healing. In a pig model, four different pulsed and continuous-wave lasers with varying wavelengths and radiant energy exposures were used to create uniform fascial graft bed thermal damage of approximately 25,160, 470, and 1100 μm. Meshed split-thickness skin graft take and healing on the thermally damaged fascial graft beds were examined on a gross and microscopic level on days 3 and 7, and then weekly up to 42 days. Results: Laser-induced thermal damage on the graft bed measuring greater than 160±60 μm in depth significantly decreased skin graft take. Other deleterious effects included delayed graft revascularization, increased inflammatory cell infiltrate at the graft-wound bed interface, and accelerated formation of hypertrophied fibrous tissue within the graft bed and underlying muscle. Conclusions: Ablative lasers developed for cutaneous surgery should create less than 160 ±60 μm of residual thermal damage to permit optimal skin graft take and healing. Pulsed carbon dioxide and 193-nm excimer lasers may be valuable instruments for the removal of full-thickness skin, skin lesions, and necrotic tissue, since they create wound beds with minimal thermal damage permitting graft take comparable to that achieved with standard surgical techniques.
UR - http://www.scopus.com/inward/record.url?scp=0027201754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027201754&partnerID=8YFLogxK
U2 - 10.1001/archderm.1993.01680290051008
DO - 10.1001/archderm.1993.01680290051008
M3 - Article
C2 - 8352622
AN - SCOPUS:0027201754
SN - 2168-6068
VL - 129
SP - 979
EP - 988
JO - Archives of Dermatology
JF - Archives of Dermatology
IS - 8
ER -